Outcome | G/C | T/C | G/C Vs T/C | ||
---|---|---|---|---|---|
Prevalence | Prevalence | Unadjusted | Adjusted OR†| Adjusted OR‡ | |
(95% CI) | (95% CI) | OR (95% CI) | (95% CI) | (95% CI) | |
Children 7–8 years of age | |||||
Current Wheeze | 8.71 | 11.43 | 0.74 | 0.73 | 0.84 |
(7.60, 9.96) | (10.21, 12.78) | (0.61, 0.90) | (0.54, 0.98) | (0.63, 1.12) | |
Severe Asthma | 2.61 | 4.93 | 0.52 | 0.67 | 0.78 |
(2.02, 3.37) | (4.13, 5.88) | (0.37, 0.71) | (0.41, 1.07) | (0.49, 1.24) | |
Current Rhinoconjuctivitis | 2.60 | 4.90 | 0.52 | 0.61 | 0.70 |
(2.00, 3.36) | (4.09, 5.84) | (0.37, 0.71) | (0.38, 0.99) | (0.43, 1.12) | |
Current Eczema | 4.72 | 3.53 | 1.36 | 1.22 | 1.38 |
(3.91, 5.69) | (2.85, 4.35) | (1.01, 1.83) | (0.79, 1.91) | (0.90, 2.13) | |
Children 13–14 years of age | |||||
Current Wheeze | 4.12 | 5.59 | 0.73 | 0.76 | 0.83 |
(3.40, 4.99) | (4.84, 6.46) | (0.56, 0.93) | (0.54, 1.05) | (0.60, 1.14) | |
Severe Asthma | 1.82 | 2.97 | 0.61 | 0.52 | 0.62 |
(1.36, 2.43) | (2.43, 3.62) | (0.42, 0.87) | (0.34, 0.85) | (0.38, 0.99) | |
Current Rhinoconjuctivitis | 4.33 | 6.64 | 0.64 | 0.72 | 0.76 |
(3.59, 5.22) | (5.81, 7.58) | (0.50, 0.81) | (0.52, 1.00) | (0.55, 1.06) | |
Current Eczema | 2.22 | 2.05 | 1.09 | 1.21 | 1.29 |
(1.71, 2.89) | (1.61, 2.61) | (0.75, 1.56) | (0.73, 2.00) | (0.78, 2.14) |